首页> 外国专利> Evaluating activity of an agent on epidermis renewal in vitro, comprises preparing equivalent of epidermis in the presence of the agent to be evaluated, where the epidermis equivalent is prepared from a population of keratinocytes

Evaluating activity of an agent on epidermis renewal in vitro, comprises preparing equivalent of epidermis in the presence of the agent to be evaluated, where the epidermis equivalent is prepared from a population of keratinocytes

机译:在体外评估药剂对表皮更新的活性,包括在要评估的药剂存在下制备等效的表皮,其中等效表皮由角质形成细胞群制备。

摘要

Evaluating activity of an agent on epidermis renewal in vitro, comprises preparing an equivalent of epidermis in the presence of the agent to be evaluated, where the epidermis equivalent is prepared from a population of keratinocytes in which the percentage of clonogenic cells with respect to total keratinocytes is modified by at least 10% with respect to the percentage of clonogenic cells of a standard population. Independent claims are included for: (1) a skin equivalent obtainable by the process, comprising the epidermis equivalent and at least one cosmetic or dermatological agent; and (2) screening cosmetic or dermatological active agents, comprising: (a) inoculating a dermis equivalent by a population of keratinocytes on a dermis equivalent in a culture medium, where the population of keratinocytes has a lower percentage of clonogenic cells of at least 10% less than the ratio of a standard population of keratinocytes; (b) contacting at least one cosmetic or dermatological active agent with keratinocytes or the culture medium; (c) leaving the epidermal equivalent for differentiating; (d) comparing the epidermal equivalent with control epidermal equivalent obtained in the same conditions but without the active agent to be evaluated; and (e) selecting the active agents for which the characteristics of proliferation and/or regeneration of the epidermis equivalent are increased with respect to cells of control epidermal equivalent. ACTIVITY : Dermatological. MECHANISM OF ACTION : None given.
机译:评估试剂在体外对表皮更新的活性,包括在要评估的试剂存在下制备等价的表皮,其中表皮等价物是由角质形成细胞群相对于总角质形成细胞的百分比的角质形成细胞制备的。相对于标准群体中克隆细胞的百分比,将其修饰至少10%。包括以下独立权利要求:(1)可通过该方法获得的皮肤等效物,包括表皮等效物和至少一种化妆品或皮肤病学试剂; (2)筛选化妆品或皮肤病学活性剂,其包括:(a)在培养基中的真皮等同物上接种一定量的真皮中的角质形成细胞,其中所述角质形成细胞的集落形成细胞的百分比较低,至少为10比标准角质形成细胞的比例低%; (b)使至少一种化妆品或皮肤病学活性剂与角质形成细胞或培养基接触; (c)将表皮等价物用于区分; (d)将表皮当量与在相同条件下获得但没有待评估活性剂的对照表皮当量进行比较; (e)选择相对于对照表皮当量细胞增加了表皮当量的增殖和/或再生特性的活性剂。活动:皮肤科。作用机理:未给出。

著录项

  • 公开/公告号FR2946662A1

    专利类型

  • 公开/公告日2010-12-17

    原文格式PDF

  • 申请/专利权人 LOREAL;

    申请/专利号FR20090054031

  • 申请日2009-06-16

  • 分类号C12Q1;

  • 国家 FR

  • 入库时间 2022-08-21 17:45:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号